SkinBioTherapeutics Plc
Commencement of a new consumer study into acne Trading update for Full Year 2023 Change of Auditor
By Elric and Alex Langton | 25 October 2023
Alex, Mike and Elric all have a financial interest in SkinBioTherapeutics.
SkinBioTherapeutics, a pioneering life science company dedicated to skin health, has taken a significant step towards addressing one of the most common skin ailments - acne. In an announcement today, the company revealed its plans for a consumer study aimed at unlocking the secrets to effective acne treatment. Additionally, SkinBioTherapeutics provided a trading update for the full year ending June 2023, revealing financial stability and a promising growth trajectory. Initially, the cash position may have spooked a few early-sell trades. Perhaps the release of the Zoom interview conducted on Sunday, which added c5p to the proceeding on Monday and Tuesday, has calmed the nerves somewhat, resulting in a 5% swing and closing 3% up at 27p.